Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.20.2
Consolidated Balance Sheets - USD ($)
Jul. 31, 2020
Apr. 30, 2020
Current Assets    
Cash $ 55,870 $ 236,668
Inventory 133,634 78,650
Other 3,020
Total Current Assets 189,504 318,338
Goodwill 2,466,073 2,466,073
Trademark 20,000 20,000
Other 3,853 3,853
TOTAL ASSETS 2,679,430 2,808,264
Current Liabilities    
Accounts payable 295,300 249,050
Accrued Expenses 99,783 89,342
Notes Payable 171,275 118,771
Due to Related Party 333,204 333,684
Customer deposits 77,053 38,419
Total Current Liabilities 976,615 829,266
Convertible debentures 450,000 450,000
Commitments and contingencies
Stockholders' Equity    
Series A Preferred Stock - shares authorized 2,200,000; outstanding 208,704; Series B Preferred Stock - shares authorized 4,300,000; outstanding 3,681,623 38,903 38,903
Common stock - shares authorized 500,000,000; outstanding 20,011,091 20,011 20,011
Additional paid-in capital 4,150,898 4,043,837
Accumulated deficit (2,956,997) (2,573,753)
Total Stockholders' Equity 1,252,815 1,528,998
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 2,679,430 $ 2,808,264